(Reuters) -All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, whose medicines are part of the second ...
Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...
An opaque system of rebates and discounts makes understanding a drug’s true price near impossible, even for experts. Can ...
A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback